首页> 外文期刊>Neuroscience: An International Journal under the Editorial Direction of IBRO >Purinergic P2 receptors trigger adenosine release leading to adenosine A(2A) receptor activation and facilitation of long-term potentiation in rat hippocampal slices.
【24h】

Purinergic P2 receptors trigger adenosine release leading to adenosine A(2A) receptor activation and facilitation of long-term potentiation in rat hippocampal slices.

机译:嘌呤能P2受体触发腺苷释放,导致腺苷A(2A)受体激活并促进大鼠海马切片的长期增强作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Electrophysiological recordings were used to investigate the effects of ATP analogues on theta-burst-induced long-term potentiation (LTP) in rat hippocampal slices. alpha,beta-Methylene ATP (alpha,beta-MeATP; 20 microM) decreased LTP from 36+/-9% to 17+/-5%, an effect prevented by adenosine A(1) receptor blockade in accordance with the localised catabolism of ATP analogues into adenosine, leading to adenosine A(1) receptor activation. Thus, to probe the role of extracellular ATP, all experiments were performed with the A(1) receptor selective antagonist, 1,3-dipropyl-8-cyclopentylxanthine (50 nM). In these conditions, alpha,beta-MeATP or 5'-adenylylimido-diphosphate (beta,gamma-ImATP; 20 microM) facilitated LTP by 120%, an effect prevented by the P2 receptor antagonists, pyridoxalphosphate-6-azophenyl-2'-4'-disulphonic acid (PPADS; 20 microM) or suramin (75 microM), as well as by the P2X(1/3)-selective antagonist 8-(benzamido)naphthalene-1,3,5-trisulfonate (10 microM). The facilitations of LTP by either alpha,beta-MeATP or beta,gamma-ImATP (20 microM) were also prevented by both 4-(2-[7-amino-2-(2-furyl(1,2,4)-triazolo(2,3a)-(1,3,5)triazin-5-yl-amino]e thyl)phenol (50 nM) or 7-2(-phenylethyl)-5-amino-2-(2-furyl)-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5- c] pyrimidine (50 nM), antagonists of facilitatory adenosine A(2A) receptors, were occluded by the A(2A) receptor agonist, CGS 21680 (10 nM) and were prevented by the protein kinase C inhibitor, chelerythrine (6 microM) and unaffected by the protein kinase A inhibitor, H89 (1 microM). Furthermore, beta,gamma-ImATP (20 microM) enhanced [(3)H]adenosine outflow from rat hippocampal slices by nearly 150%, an effect prevented by PPADS (20 microM) or suramin (75 microM). The adenosine transport inhibitors, nitrobenzylthioinosine (5 microM) and dipyridamole (10 microM) also prevented beta,gamma-ImATP (20 microM)-induced [(3)H]adenosine outflow and facilitation of LTP. These results suggest that ATP analogues facilitate LTP through P2 receptor activation that mainly triggers adenosine release leading to the activation of adenosine A(2A) receptors.
机译:使用电生理记录来研究ATP类似物对大鼠海马切片中theta-burst诱导的长期增强(LTP)的影响。 α,β-亚甲基ATP(α,β-MeATP; 20 microM)将LTP从36 +/- 9%降低至17 +/- 5%,这是腺苷A(1)受体根据局部分解代谢而阻止的作用ATP类似物转变为腺苷,导致腺苷A(1)受体激活。因此,为探究细胞外ATP的作用,所有实验均使用A(1)受体选择性拮抗剂1,3-二丙基-8-环戊基黄嘌呤(50 nM)进行。在这些情况下,α,β-MeATP或5'-腺苷酰二磷酸(β,γ-ImATP; 20 microM)促进LTP达到120%,P2受体拮抗剂吡ido醛磷酸盐-6-偶氮苯基2'- 4'-二磺酸(PPADS; 20 microM)或苏拉明(75 microM)以及P2X(1/3)-选择性拮抗剂8-(苯甲酰胺基)萘-1,3,5-三磺酸盐(10 microM) 。 4-(2- [7-氨基-2-(2-呋喃基(1,2,4)-)和α-,β-MeATP或β,γ-ImATP(20 microM)对LTP的促进作用也被阻止三唑并(2,3a)-(1,3,5)三嗪-5-基-氨基] e乙基)苯酚(50 nM)或7-2(-苯乙基)-5-氨基-2-(2-呋喃基) -pyrazolo- [4,3-e] -1,2,4-triazolo [1,5-c]嘧啶(50 nM)是促进型腺苷A(2A)受体的拮抗剂,被A(2A)受体阻塞激动剂CGS 21680(10 nM),被蛋白激酶C抑制剂白屈菜红碱(6 microM)所阻止,而不受蛋白激酶A抑制剂H89(1 microM)的影响;此外,β,γ-ImATP(20 microM)增强了[(3)H]腺苷从大鼠海马片中流出近150%,PPADS(20 microM)或苏拉明(75 microM)阻止了这种作用;腺苷转运抑制剂,硝基苄基硫代肌苷(5 microM)和双嘧达莫(10 microM)阻止了β,γ-ImATP(20 microM)诱导的[(3)H]腺苷流出和LTP的促进。这些结果表明ATP类似物通过主要触发腺苷释放的P2受体激活来活化LTP LTP,从而导致腺苷A(2A)受体激活。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号